杆菌感染和帕金森病:病因,病原和莱沃多巴生物可用性
Bang-Rong Wei1, Yu-Jia Zhao1, Yu-Feng Cheng1
1Key Laboratory of Basic Pharmacology of Ministry of Education and Joint International Research Laboratory of Ethnomedicine of Ministry of Education and Key Laboratory of Basic Pharmacology of Guizhou Province and Laboratory Animal Centre, Zunyi Medical University, Zunyi, Guizhou, China.
Immunity & ageing : I & A
|January 3, 2024
概括
杆菌感染越来越多地与帕金森病 (PD) 的发病有关. 本综述探讨了H. pylori如何影响PD发展和乐伏多巴治疗疗效.
科学领域:
- 神经科学是一个神经科学.
- 胃肠病学 胃肠病学
- 微生物学 微生物学
背景情况:
- 帕金森病 (PD) 是一种神经退行性疾病,其特点是多巴胺神经元损失,患病率不断上升,病因不明.
- 杆菌 (H. pylori) 感染在全球广泛传播,新出现的证据表明它与PD有关.
- 由于PD的未确定的原因限制了有效的治疗干预措施.
研究的目的:
- 审查H.pylori感染在帕金森病病因和病变发生中的多方面的作用.
- 检查H. pylori对勒沃多巴生物可用性和PD患者治疗疗效的影响.
- 阐明H. pylori对神经炎症和与PD相关的肠道失调有助于产生神经炎症的机制.
主要方法:
- 文献综述综合了关于H. pylori感染和帕金森病的当前研究.
- 分析拟议的机制,包括H. pylori诱导的炎症,肠道微生物群的破坏,以及对血脑屏障的影响.
- 对H. pylori对列伏多巴吸收和药理动学的影响的评估.
主要成果:
- 杆菌感染通过诸如促炎性细胞因子释放等机制导致PD,导致中心炎症和神经元损伤.
- 杆菌破坏肠道微生物群,导致小肠细菌过度生长 (SIBO),这会影响肠-大脑轴和莱沃多巴的吸收.
- 杆菌可以诱导胃衰竭,改变血脑屏障的透性,并可能利用利沃多巴,进一步复杂化PD管理.
结论:
- 杆菌感染是帕金森病病因和进展的一个重要,但经常被忽视的因素.
- 细菌对肠道健康,炎症和药物生物可用性的影响需要在PD治疗策略中考虑.
- 对H.pylori-PD联系的进一步研究可能会揭示神经保护和改善利沃多巴治疗的新疗法标.
相关概念视频
01:24Parkinson's Disease: Treatment
273
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
273
01:15Parkinson's Disease: Overview
553
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
553
01:22Pathophysiology of Peptic Ulcer Disease: Injurious Factors
592
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
592
01:30Peptic Ulcer Disease I: Introduction
173
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
173
01:24Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
430
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
430
01:22Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K